Get startedLog in
    Picture of Revance Therapeutics logo

    RVNC — Revance Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapNeutral
    All News

    Brief: Crown Laboratories Commences Friendly Tender Offer For All Outstanding Common Shares Of Revance Therapeutics At $3.10 Per Share

    Picture of Revance Therapeutics logoRevance Therapeutics
    12/12/2024 13:21
    Dec 12 (Reuters) - Revance Therapeutics  RVNC.O :
    * CROWN LABORATORIES COMMENCES FRIENDLY TENDER OFFER FOR ALL
OUTSTANDING COMMON SHARES OF REVANCE THERAPEUTICS AT $3.10 PER
SHARE
    * CROWN LABORATORIES: TENDER OFFER IS SCHEDULED TO EXPIRE AT
ONE
MINUTE AFTER 11:59 P.M., EASTERN TIME ON JANUARY 13, 2025

Source text:  ID:nPn9L9sPDa 
Further company coverage:  RVNC.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Revance Therapeutics

    See all news